Literature DB >> 9309700

Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis.

J M Schröder1, M Molnar.   

Abstract

Computer retrieval in a database, comprising 7,225 muscle cases, revealed that mitochondrial myopathies do not occur more frequently in inflammatory myopathies (3.74%) than in the whole series (3.69%). A more detailed study of inclusion body myositis (IBM), however, showed that severe mitochondrial alterations were apparent in about twice as many IBM cases as expected. This confirms recent studies of others although a causal relationship has thus far not been established. Identification of mitochondrial deletions by Southern blotting corresponded to the presence of severe structural abnormalities of mitochondria. Peripheral neuropathy of variable severity was noted in all cases of IBM and mitochondrial myopathy. By contrast, the association of severe mitochondrial abnormalities with polymyositis, systemic scleroderma, and vasculitis observed in some cases of the present series may be incidental or age dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309700

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  9 in total

1.  Increase of mitochondria in vasa nervorum of cases with mitochondrial myopathy, Kearns-Sayre syndrome, progressive external ophthalmoplegia and MELAS.

Authors:  M Molnar; S Neudecker; J M Schröder
Journal:  Neuropathol Appl Neurobiol       Date:  1995-10       Impact factor: 8.090

2.  Electrophysiological spectrum of inclusion body myositis.

Authors:  J L Joy; S J Oh; A I Baysal
Journal:  Muscle Nerve       Date:  1990-10       Impact factor: 3.217

3.  Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients.

Authors:  F M Santorelli; M Sciacco; K Tanji; S Shanske; T H Vu; V Golzi; R C Griggs; J R Mendell; A P Hays; T E Bertorini; A Pestronk; E Bonilla; S DiMauro
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

4.  A large-scale deletion of mitochondrial DNA in a case with pure mitochondrial myopathy and neuropathy.

Authors:  M Molnar; S Zanssen; G Buse; J M Schröder
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

5.  Mitochondrial DNA deletions in muscle fibers in inclusion body myositis.

Authors:  A Oldfors; A R Moslemi; I M Fyhr; E Holme; N G Larsson; C Lindberg
Journal:  J Neuropathol Exp Neurol       Date:  1995-07       Impact factor: 3.685

Review 6.  Neuropathy associated with mitochondrial disorders.

Authors:  J M Schröder
Journal:  Brain Pathol       Date:  1993-04       Impact factor: 6.508

Review 7.  Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy, hereditary and non-hereditary neuropathies, and review of the literature.

Authors:  J M Schröder; C Sommer
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Inclusion body myositis. A corticosteroid-resistant idiopathic inflammatory myopathy.

Authors:  M J Danon; M G Reyes; O H Perurena; J C Masdeu; J R Manaligod
Journal:  Arch Neurol       Date:  1982-12

9.  Ragged red fibers in normal aging and inflammatory myopathy.

Authors:  Z Rifai; S Welle; C Kamp; C A Thornton
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

  9 in total
  3 in total

Review 1.  Endoplasmic reticulum stress in skeletal muscle homeostasis and disease.

Authors:  Sree Rayavarapu; William Coley; Kanneboyina Nagaraju
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

2.  Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness.

Authors:  Sree Rayavarapu; William Coley; Travis B Kinder; Kanneboyina Nagaraju
Journal:  Skelet Muscle       Date:  2013-06-07       Impact factor: 4.912

Review 3.  Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathy.

Authors:  Clara Crescioli
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.